![John G. Vossen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
John G.
Vossen is currently the Director-Supervisory Board at FABPulous BV.
He previously worked as an Investment Manager at NV Limburgs Instituut voor Ontwikkeling en Financiering and Brabantse Ontwikkelings Maatschappij Holding BV.
From 2010 to 2014, he was a Partner at Limburg Ventures (Management).
He also worked as a Partner at Brightlands Venture Partners BV from 2014 to 2015.
Postes actifs de John G. Vossen
| Sociétés | Poste | Début |
|---|---|---|
FABPulous BV
 FABPulous BV Medical SpecialtiesHealth Technology Develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability | Directeur/Membre du Conseil | 15/12/2010 |
Anciens postes connus de John G. Vossen
| Sociétés | Poste | Fin |
|---|---|---|
Brightlands Venture Partners BV
 Brightlands Venture Partners BV Investment ManagersFinance Brightlands Venture invests in companies located in Europe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital requirements with an investment size of EUR 0.25 - EUR 2 million. It acts as lead and co-investor and makes follow-on investments. | Private Equity Investor | 30/06/2015 |
Brabantse Ontwikkelings Maatschappij Holding BV
 Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe, primarily in Netherlands. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 31/12/2014 |
Limburg Ventures (Management)
 Limburg Ventures (Management) Investment ManagersFinance LVM is an active manager which invests in start-up companies in the life sciences (cardiovascular and oncology research, nutrition and health, biomaterials and biomedical devices and biopharmaceuticals) and advanced materials sectors (functional polymers, coatings and films, formulations and processing activities) which relocate to the Dutch province of Limburg. The firm typically invests between EUR 0.25-2 million in companies still in the start-up phase which are close to achieving proof-of-principle status, ready to scale up and commercialize proprietary technology. In certain cases, they also invest in companies supplying or servicing such firms. LVM acts as lead investor and also participates as a co-investor in a syndicate. They generally take a board seat, partnering with investee company management to help create value. | Director of Investments | 22/03/2010 |
NV Limburgs Instituut voor Ontwikkeling en Financiering
 NV Limburgs Instituut voor Ontwikkeling en Financiering Investment ManagersFinance NV Limburgs Instituut voor Ontwikkeling en Financiering invests in small and mid-size companies located in Netherlands. The firm targets companies operating in the field of ICT, technology-related, life science, manufacturing, chemicals, new materials, automotive services, consumer non-durables, leisure and health sectors. It provides financing for pre-seed, seed, early and start-up, to expansion capital requirements and also makes co-investments. It acquires majority and minority interests. | Private Equity Investor | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
NV Limburgs Instituut voor Ontwikkeling en Financiering
NV Limburgs Instituut voor Ontwikkeling en Financiering Investment ManagersFinance NV Limburgs Instituut voor Ontwikkeling en Financiering invests in small and mid-size companies located in Netherlands. The firm targets companies operating in the field of ICT, technology-related, life science, manufacturing, chemicals, new materials, automotive services, consumer non-durables, leisure and health sectors. It provides financing for pre-seed, seed, early and start-up, to expansion capital requirements and also makes co-investments. It acquires majority and minority interests. | Finance |
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe, primarily in Netherlands. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Limburg Ventures (Management)
Limburg Ventures (Management) Investment ManagersFinance LVM is an active manager which invests in start-up companies in the life sciences (cardiovascular and oncology research, nutrition and health, biomaterials and biomedical devices and biopharmaceuticals) and advanced materials sectors (functional polymers, coatings and films, formulations and processing activities) which relocate to the Dutch province of Limburg. The firm typically invests between EUR 0.25-2 million in companies still in the start-up phase which are close to achieving proof-of-principle status, ready to scale up and commercialize proprietary technology. In certain cases, they also invest in companies supplying or servicing such firms. LVM acts as lead investor and also participates as a co-investor in a syndicate. They generally take a board seat, partnering with investee company management to help create value. | Finance |
FABPulous BV
FABPulous BV Medical SpecialtiesHealth Technology Develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability | Health Technology |
Brightlands Venture Partners BV
Brightlands Venture Partners BV Investment ManagersFinance Brightlands Venture invests in companies located in Europe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital requirements with an investment size of EUR 0.25 - EUR 2 million. It acts as lead and co-investor and makes follow-on investments. | Finance |
